At a glance
ClinicalIndex Comparison RecordN/ACompleted· 816 enrolled
Drug / intervention
Bausch + Lomb Samfilcon A Soft Contact Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Soft Contact Lens When Worn on a 7-Day Extended Wear Basis
In Brief
A clinical study evaluating Bausch + Lomb Samfilcon A Soft Contact Lens and Bausch + Lomb Pure Vision Soft Contact Lens for Myopia. Completed, enrolled 816 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the safety and effectiveness of the Bausch + Lomb samfilcon A soft (hydrophilic) contact lens, a new silicone hydrogel contact lens, compared to the Bausch + Lomb PureVision® soft contact lens when worn for 7-day extended wear by adapted soft contact lens wearers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2015
Primary CompletionAug 2016
First PostedOct 2016
TodayJul 2026
First PostedOct 20, 2016
Enrollment StartApr 30, 2015
Primary CompletionAug 3, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.7 years ago
Interventions
Bausch + Lomb Samfilcon A Soft Contact Lensdevice
soft contact lenses
Bausch + Lomb Pure Vision Soft Contact Lensdevice
soft contact lenses